MedPath
NMPA Approval

Lurasidone Hydrochloride Tablets

H20190021

January 24, 2019

Drug Information

盐酸鲁拉西酮片

罗舒达

罗舒达

片剂

40mg(按C28H36N4O2S·HCl计)

化学药品

January 24, 2019

January 23, 2024

Company Information

Applicant Company

84 Waterford Drive, Marlborough, MA 01752 United States of America

Manufacturing Company

bushu pharmaceuticals ltd. kawagoe factory

1 Takeno, Kawagoe, Saitama, 350-0801, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸鲁拉西酮片 - NMPA 批准文号 | MedPath